At The University of Texas MD Anderson Cancer Center, I lead translational and clinical epidemiology studies evaluating screening technologies, biomarkers, and prevention strategies across several cancer types. I synthesize clinical, genomic, and behavioral data to inform risk-based patient management and precision prevention.
I co-lead multidisciplinary research teams and serve as a Co-Principal Investigator or Co-Investigator on NIH, NCI, CPRIT, and foundation-funded studies. My research has included evaluating molecular assays for high-risk HPV and precancerous lesions, as well as clinical outcomes and cost-effectiveness across cancer cohorts.
Through the Africa Cervical and Breast Cancer Prevention & Control Program (ECHO AFROGIN), I direct telementoring sessions that connect frontline clinicians with oncology specialists. I also translate oncology guidelines and clinical trial findings into educational curricula.
As a consultant and scientific committee member with WHO/IARC and IAEA, I advise on cancer control strategies, diagnostic technologies, and clinical program evaluation. I’m a co-author of more than 100 peer-reviewed publications and have worked across clinical oncology, molecular epidemiology, and translational cancer research.

